My designs, from art to prepress, of toolkits and brochures created in 2012/2011.

1. ©Jeffrey Slater 2012

2. ©Jeffrey Slater 2012

3. ©Jeffrey Slater 2012

4. ©Jeffrey Slater 2012

5. ©Jeffrey Slater 2012

6. ©Jeffrey Slater 2012

7. ©Jeffrey Slater 2012

8. NEW
Updated Coding
Information
Updated Coding
Information
Coding and Billing Summary
for YERVOY™ (ipilimumab)
©Jeffrey Slater 2012
Coding and Billing Summary Updated Coding INDICATION
for YERVOY™ (ipilimumab) Information YERVOY (ipilimumab) is indicated for the treatment
of unresectable or metastatic melanoma.
Coding and Billing Summary
INDICATION
for YERVOY™ (ipilimumab)
YERVOY (ipilimumab) is indicated for the treatment
of unresectable or metastatic melanoma.
Please see Important Safety Information, including Boxed WARNING
regarding immune-mediated adverse reactions, on inside spread. INDICATION
YERVOY (ipilimumab) is indicated for the treatment
of unresectable or metastatic melanoma.
Please see Important Safety Information, including Boxed WARNING
regarding immune-mediated adverse reactions, on inside spread.
Please see Important Safety Information, including Boxed WARNING
regarding immune-mediated adverse reactions, on inside spread.

9. ©Jeffrey Slater 2012